Bausch Health Companies Inc (NYSE:BHC) shares traded -10.90% lower at $6.54 on Wall Street last session.
BHC stock price is now -15.20% away from the 50-day moving average and -10.88% away from the 200-day moving average. The market capitalization of the company currently stands at $2.41B.
With the price target reduced from $9 to $3, Piper Sandler Downgraded its rating from Neutral to Underweight for Bausch Health Companies Inc (NYSE: BHC). On July 10, 2024, Raymond James recently initiated its ‘Mkt Perform’ rating on the stock quoting a target price of $8, while ‘Jefferies’ rates the stock as ‘Buy’
In other news, Carson Seana, EVP, General Counsel sold 440 shares of the company’s stock on Dec 02 ’24. The stock was sold for $3,674 at an average price of $8.35. Upon completion of the transaction, the EVP, General Counsel now directly owns 433,066 shares in the company, valued at $2.83 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Dec 02 ’24, Officer Carson Seana bought 440 shares of the business’s stock. A total of $3,674 was incurred on buying the stock at an average price of $8.35. A total of 20.88% of the company’s stock is owned by insiders.
During the past 12 months, Bausch Health Companies Inc has had a low of $3.96 and a high of $11.46. The fifty day moving average price for BHC is $7.7454 and a two-hundred day moving average price translates $7.3489 for the stock.
The latest earnings results from Bausch Health Companies Inc (NYSE: BHC) was released for 2024-09-30. The company reported revenue of $2.51 billion for the quarter, compared to $2.24 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 12.15 percent.
